Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma
Purpose
This Expanded Access Program (EAP) is intended to provide daraxonrasib to eligible adult patients with previously treated metastatic pancreatic adenocarcinoma, who have no comparable or satisfactory alternative therapy and are unable to participate in an ongoing daraxonrasib clinical trial.
Conditions
- PDAC
- PDAC - Pancreatic Ductal Adenocarcinoma
- Metastatic Pancreas Adenocarcinoma
- Pancreatic Cancer
- Pancreatic Cancer Metastatic
- Pancreatic Adenocarcinoma Metastatic
- Pancreatic Adenocarcinoma
- Pancreatic Adenosquamous Carcinoma
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- At least 18 years old and has provided informed consent. - Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. - Histologically or cytologically confirmed PDAC with metastatic disease. - Evidence of active disease progression during or following the most recent line of systemic therapy for PDAC, based on investigator assessment. - At least one prior line of systemic therapy in the metastatic setting, which must include either a fluoropyrimidine-based or gemcitabine-based regimen. - Received and progressed, been intolerant to prior standard therapy, or no longer expected to benefit from standard therapies. - Adequate bone marrow, renal, hepatic, and coagulation functions. - Ineligible for, or unable to enroll in, another clinical trial of daraxonrasib, if available. - Able to take oral medications
Exclusion Criteria
- History of known central nervous system metastatic disease. - Concurrent systemic anticancer therapy. - Significant cardiovascular disease. - Major GI conditions that may affect the ability to take or absorb daraxonrasib (patients with prior Whipple procedure are eligible). - Active uncontrolled systemic infection. - Major surgery within 28 days before enrollment. - Additional inclusion and exclusion criteria may apply.
Study Design
- Phase
- Study Type
- Expanded Access
Recruiting Locations
Daphne, Alabama 36526
Mobile, Alabama 36608
Anchorage, Alaska 99508
Casa Grande, Arizona 85122
Phoenix, Arizona 85054
Scottsdale, Arizona 85258
Tucson, Arizona 85719
Fort Smith, Arkansas 72903
Hot Springs, Arkansas 71913
Chula Vista, California 91911
Duarte, California 91010
Fountain Valley, California 92708
Fresno, California 93720
Los Angeles, California 90033
Los Angeles, California 90048
Los Angeles, California 90095
Los Angeles, California 90095
Mountain View, California 94040
Oakland, California 94158
Orange, California 92612
Palm Springs, California 92262
Roseville, California 95661
Sacramento, California 95816
San Francisco, California 94115
San Luis Obispo, California 93401
Stanford, California 94305
Vacaville, California 95687
Walnut Creek, California 94598
Aurora, Colorado 80012
Denver, Colorado 80210
Denver, Colorado 80211
Durango, Colorado 81301
Fort Collins, Colorado 80528
New Haven, Connecticut 06519
Boca Raton, Florida 33487
Hollywood, Florida 33021
Jacksonville, Florida 32224
Miami, Florida 33136
Miami, Florida 33176
Miami Beach, Florida 33140
Naples, Florida 32746
Orlando, Florida 32803
Orlando, Florida 33308
Tampa, Florida 33612
Atlanta, Georgia 30318
Atlanta, Georgia 30322
Columbus, Georgia 31904
Marietta, Georgia 30060
Honolulu, Hawaii 96813
Boise, Idaho 83712
Arlington Heights, Illinois 60005
Chicago, Illinois 60637
Downers Grove, Illinois 60515
Naperville, Illinois 60126
Peoria, Illinois 61637
Quincy, Illinois 62301
Rolling Meadows, Illinois 60008
Zion, Illinois 60099
Indianapolis, Indiana 46202
Newburgh, Indiana 47630
Ames, Iowa 50010
Bettendorf, Iowa 52722
Waukee, Iowa 50263
Merriam, Kansas 66204
Westwood, Kansas 66205
Wichita, Kansas 67214
Edgewood, Kentucky 41017
Lexington, Kentucky 40503
Louisville, Kentucky 40217
Owensboro, Kentucky 42303
New Orleans, Louisiana 70112
Topsham, Maine 04086
Baltimore, Maryland 21231
Boston, Massachusetts 02114
Boston, Massachusetts 02215
Boston, Massachusetts 02215
Natick, Massachusetts 01760
Ann Arbor, Michigan 48109
Detroit, Michigan 48201
Detroit, Michigan 48202
Grand Rapids, Michigan 49546
Royal Oak, Michigan 48073
Ypsilanti, Michigan 48197
Edina, Minnesota 55435
Rochester, Minnesota 55905
Saint Louis Park, Minnesota 55426
Saint Louis Park, Minnesota 55426
Saint Paul, Minnesota 55101
Jackson, Mississippi 39202
Joplin, Missouri 64804
Kansas City, Missouri 64111
Kansas City, Missouri 64132
Springfield, Missouri 65807
St Louis, Missouri 63128
St Louis, Missouri 63141
St Louis, Missouri 63141
Lincoln, Nebraska 68506
Omaha, Nebraska 68114
Omaha, Nebraska 68130
Lebanon, New Hampshire 03756
Camden, New Jersey 08103
Morristown, New Jersey 07960
New Brunswick, New Jersey 08903
Brooklyn, New York 11206
Lake Success, New York 11042
Long Island City, New York 11101
New York, New York 10016
New York, New York 10022
New York, New York 10029
New York, New York 11967
Rochester, New York 14626
The Bronx, New York 10461
Durham, North Carolina 27710
Huntersville, North Carolina 28078
Canfield, Ohio 44406
Cleveland, Ohio 44106
Columbus, Ohio 43214
Columbus, Ohio 43219
Columbus, Ohio 43221
Dayton, Ohio 45459
Middletown, Ohio 45005
Oklahoma City, Oklahoma 73120
Happy Valley, Oregon 97223
Portland, Oregon 97213
Salem, Oregon 97301
Springfield, Oregon 97477
Allentown, Pennsylvania 18103
Butler, Pennsylvania 15212
Dunmore, Pennsylvania 18512
Media, Pennsylvania 19063
Natrona Heights, Pennsylvania 15212
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19107
Philadelphia, Pennsylvania 19111
Sayre, Pennsylvania 18840
Charleston, South Carolina 29414
Rapid City, South Dakota 57701
Sioux Falls, South Dakota 57105
Germantown, Tennessee 38138
Knoxville, Tennessee 37919
Memphis, Tennessee 38120
Nashville, Tennessee 37203
Nashville, Tennessee 37203
Edinburg, Texas 78539
Houston, Texas 77030
Houston, Texas 77030
Pearland, Texas 77584
Richardson, Texas 75082
Salt Lake City, Utah 84106
Salt Lake City, Utah 84112
Burlington, Vermont 05401
Fairfax, Virginia 22031
Fredericksburg, Virginia 22408
Hampton, Virginia 23606
Newport News, Virginia 23320
Richmond, Virginia 23229
Kennewick, Washington 99336
Renton, Washington 98057
Seattle, Washington 98101
Seattle, Washington 98104
Seattle, Washington 98109
Walla Walla, Washington 99362
Appleton, Wisconsin 54611
Grafton, Wisconsin 53024
La Crosse, Wisconsin 05461
Madison, Wisconsin 53792
Marshfield, Wisconsin 54449
Milwaukee, Wisconsin 53226
Waukesha, Wisconsin 53072
San Juan, Puerto Rico 00909
More Details
- NCT ID
- NCT07573215
- Status
- Available
- Sponsor
- Revolution Medicines, Inc.
Detailed Description
This EAP has been established to provide access to daraxonrasib to patients with previously treated metastatic pancreatic adenocarcinoma during the period before potential commercial availability. Patients may be eligible if they have progressed on, are intolerant of, or are no longer expected to benefit from available standard therapies, and if they are not able to enroll in a clinical trial of daraxonrasib due to ineligibility or lack of access. This EAP is intended to address an unmet medical need and is not designed to support clinical development objectives. Daraxonrasib is an investigational, orally administered, RAS(ON) inhibitor administered as monotherapy. Daraxonrasib will be supplied by the Sponsor free of charge during the duration of treatment under this program.